Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New Pacer--PLAINTIFFS' AGREED-IN-PART MOTION TO CONTINUE DISCOVERY AND TRIAL MOTION TO CONTINUE DISCOVERY AND TRIAL
The intervenor ARM defendants have not been involved in these discussions, and have not agreed to the continuance; however, based on this Court's Markman ruling requiring all operands in an "instruction group" to be right justified, TPL has stipulated to non-infringement, and requested agreement to entry of a stipulated judgment of noninfringement pursuant to FRCP Rule 54(b). The parties are in the process of ironing out the language needed to implement such a Continued on the next page
MOTION TO CONTINUE DISCOVERY AND TRIAL 763 F.2d 1374, 1379-80 (11th Cir. 1985); Szeliga v. General Motors Corp., 728 F.2d 566, 568 (1st Cir. 1984); Conway v. Chemical Leaman Tank Lines, Inc., 687 F.2d 108, 112 (5th Cir. 1982).
IV. CONCLUSION
Share
New Message
Please login to post a reply